Company Filing History:
5 out of 263 
4 out of 27 
1 out of 1 Years Active: 2013-2021
Title: Inventor Spotlight: Anne Louise Sørensen
Introduction
Anne Louise Sørensen, an innovative inventor based in Copenhagen, Denmark, is making significant strides in the field of immunology. With a portfolio of five patents, her work focuses on developing methods and compositions to induce cancer-specific immune responses, particularly targeting the MUC1 antigen.
Latest Patents
One of Anne's latest patents revolves around the generation of a cancer-specific immune response toward MUC1 and the development of cancer-specific MUC1 antibodies. This invention outlines a method for inducing a cancer-specific immune response against MUC1 using an immunogenic glycopeptide. It also includes aspects of a pharmaceutical composition comprising the immunogenic glycopeptide and a cancer vaccine that utilizes the same glycopeptide. Another noteworthy aspect of this invention is the creation of an antibody generated using the immunogenic glycopeptide, which has potential applications in both therapy and diagnosis.
Career Highlights
Anne has contributed her expertise to esteemed institutions, notably working with Cancer Research Technology Limited and Københavns Universitet. Her career is distinguished by her commitment to advancing cancer research and immunotherapy.
Collaborations
Throughout her career, Anne has collaborated with prominent figures in her field, including Henrik Clausen and Joy Burchell. Their joint efforts highlight the importance of teamwork in the pursuit of groundbreaking inventions in cancer treatment and research.
Conclusion
With her remarkable contributions and innovative inventions, Anne Louise Sørensen continues to pave the way for advancements in cancer immunotherapy. Her work not only enhances our understanding of immune responses to cancer but also opens new avenues for therapeutic development, showcasing the vital role of inventors in the ongoing battle against cancer.